High prevalence of developmental coordination disorder risk in childhood apraxia of speech
Developmental Medicine & Child Neurology · 2025
DOI: 10.1111/dmcn.70099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, 2025. Verfasst von Şermin Tükel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Research Excellence in Speech and Language, Murdoch Children's Research Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Apraxias, Motor Skills Disorders, Speech Disorders. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Health and Medical Research Council, Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.
Abstract (Originalsprache)
Aim
To explore motor impairments linked to developmental coordination disorder (DCD) in children with childhood apraxia of speech (CAS).
Method
This prospective cohort study included 105 children (79 male, aged 5–15 years) with CAS. Assessments included the Developmental Coordination Disorder Questionnaire, Revised, the visuomotor precision subtest of the Neuropsychological Assessment, Second Edition, the motor subtest of the Vineland Adaptive Behaviour Scales, Third Edition (Vineland‐3), and Full‐scale IQ (FSIQ) scores. Data analysis used multiple imputation for missing data, along with descriptive statistics, repeated‐measures analysis of variance, multiple binary logistic regression, and receiver operating characteristic (ROC) analyses.
Results
Eighty‐two per cent of participants showed motor impairments; 63% screened positive for DCD risk; and 71% had visuomotor precision impairments. Fine‐motor scores were lower than gross‐motor and coordination scores. The logistic regression model accurately predicted DCD risk at 73%, identifying the Vineland‐3 (odds ratio [OR] = 7.17) and visuomotor precision subtest (OR = 4.90) as significant predictors, whereas the FSIQ was not. The Vineland‐3 showed a high false negative rate (46%) for DCD risk, and the ROC analysis suggested a higher cut‐off point for improved prediction accuracy.
Interpretation
This study highlights a high prevalence of DCD risk and visuomotor precision impairments among children with CAS, independent of FSIQ. The Vineland‐3 motor subtest is not recommended for DCD assessment, whereas screening for DCD is essential for targeted interventions in CAS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre of Research Excellence in Speech and Language, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
- Department of Physiotherapy and Rehabilitation, Izmir University of Economics, Izmir, Turkiye.
- Department of Mathematics, Izmir University of Economics, Izmir, Turkiye.
- Research Theme of Genetics Disorders, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
- Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
- Department of Developmental Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.
ORCID-Profile: Şermin Tükel, Emma K Baker, David J Amor, Angela T Morgan
Förderung
- National Health and Medical Research Council
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Zitieren
APA
Tükel, Ş., Baker, E. K., Tütüncü, G. Y., O'Donnell, L., Lauretta, M., Brenchley, C., Amor, D. J., & Morgan, A. T. (2025). High prevalence of developmental coordination disorder risk in childhood apraxia of speech. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.70099
Vancouver
Tükel Ş, Baker EK, Tütüncü GY, O'Donnell L, Lauretta M, Brenchley C, et al. High prevalence of developmental coordination disorder risk in childhood apraxia of speech. Developmental Medicine & Child Neurology. 2025. doi:10.1111/dmcn.70099
BibTeX
@article{Tkel2025,
author = {Tükel, Şermin and Baker, Emma K and Tütüncü, G Yazgi and O'Donnell, Lorraine and Lauretta, Mariana and Brenchley, Celia and Amor, David J and Morgan, Angela T},
title = {High prevalence of developmental coordination disorder risk in childhood apraxia of speech},
journal = {Developmental Medicine & Child Neurology},
year = {2025},
doi = {10.1111/dmcn.70099}
}
EUVIMED